Cargando…
Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia
BACKGROUND: Chronic lymphocytic leukemia (CLL) is the most frequent, and still incurable, form of leukemia in the Western World. It is widely accepted that cancer results from an evolutionary process shaped by the acquisition of driver mutations which confer selective growth advantage to cells that...
Autores principales: | Hortal, Alejandro M., Oeste, Clara L., Cifuentes, Claudia, Alcoceba, Miguel, Fernández-Pisonero, Isabel, Clavaín, Laura, Tercero, Rut, Mendoza, Pilar, Domínguez, Verónica, García-Flores, Marta, Pintado, Belén, Abia, David, García-Macías, Carmen, Navarro-Bailón, Almudena, Bustelo, Xosé R., González, Marcos, Alarcón, Balbino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815240/ https://www.ncbi.nlm.nih.gov/pubmed/35120522 http://dx.doi.org/10.1186/s12943-022-01496-x |
Ejemplares similares
-
An Optimized Single Nucleotide Polymorphism-Based Detection Method Suggests That Allelic Variants in the 3’ Untranslated Region of RRAS2 Correlate with Treatment Response in Chronic Lymphocytic Leukemia Patients
por: Hortal, Alejandro, et al.
Publicado: (2023) -
RRAS2 shapes the TCR repertoire by setting the threshold for negative selection
por: Martínez-Riaño, Ana, et al.
Publicado: (2019) -
RRas2, RhoG and T-cell phagocytosis
por: Alarcón, Balbino, et al.
Publicado: (2012) -
Recreation of an antigen-driven germinal center in vitro by providing B cells with phagocytic antigen
por: Martínez-Riaño, Ana, et al.
Publicado: (2023) -
Characterization of mutant versions of the R-RAS2/TC21 GTPase found in tumors
por: Clavaín, Laura, et al.
Publicado: (2022)